Jan 18, 2022 05:29 PM (GMT+8) · EqualOcean
Financial Associated Press, January 18 - Runda medical announced that the company's wholly-owned subsidiary Shanghai Huizhong Biotechnology Co., Ltd. (hereinafter referred to as "Huizhong biotechnology") and orsendor Biotechnology Development (Shanghai) Co., Ltd. (hereinafter referred to as "orsendor biotechnology"), a wholly-owned subsidiary of orsendor in China, signed a strategic cooperation and joint venture agreement to establish a joint venture with a registered capital of 2 million yuan, The company plans to invest 1 million yuan with its own funds, accounting for 50% of the registered capital of the joint venture.

This text is a result of machine translation.